La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Etude comparative And NotAndrew P. Duker

List of bibliographic references

Number of relevant bibliographic references: 69.
Ident.Authors (with country if any)Title
000008 Kay Teschke [Canada] ; Stephen A. Marion [Canada] ; Joseph K. C. Tsui [Canada] ; HUI SHEN [Canada] ; Kathrine Rugbjerg [Canada, Danemark] ; M. Anne Harris [Canada]Parkinson's Disease and Occupation: Differences in Associations by Case Identification Method Suggest Referral Bias
000033 Mauro Pettorruso [Italie] ; Giovanni Martinotti [Italie] ; Alfonso Fasano [Canada] ; Giovanna Loria [Italie] ; Marco Di Nicola [Italie] ; Luisa De Risio [Italie] ; Lucia Ricciardi [Italie] ; Gianluigi Conte [Italie] ; Luigi Janiri [Italie] ; Anna Rita Bentivoglio [Italie]Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study
000081 Alexander M. Crizzle [Canada] ; Anita M. Myers [Canada]Examination of naturalistic driving practices in drivers with Parkinson's disease compared to age and gender-matched controls
000360 Sarah C. Lidstone [Canada] ; Michael Schulzer [Canada] ; Katherine Dinelle [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; A. Jon Stoessl [Canada]Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
000363 Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]Early Versus Delayed Bilateral Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Decision Analysis
000475 Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
000485 M. Mallar Chakravarty [Canada] ; Abbas F. Sadikot [Canada] ; Jürgen Germany [Canada] ; Pierre Hellier [France] ; Gilles Bertrand [Canada] ; D. Louis Collins [Canada]Comparison of Piece-Wise Linear, Linear, and Nonlinear Atlas-to-Patient Warping Techniques: Analysis of the Labeling of Subcortical Nuclei for Functional Neurosurgical Applications
000499 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]A Comparison of Treatment Thresholds in Two Large Parkinson's Disease Clinical Trial Cohorts
000503 Magdalena Szczerbowska-Boruchowska [Pologne]X-ray fluorescence spectrometry, an analytical tool in neurochemical research
000521 Stephen J. Kish [Canada] ; JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada]Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
000563 Yuri M. Andrade-Souza [Canada] ; Jason M. Schwalb [Canada] ; Clement Hamani [Canada] ; Hazem Eltahawy [Canada] ; Tasnuva Hoque [Canada] ; Jean Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Roy A. E. Bakay ; Ali R. Rezai ; Philip A. StarrCOMPARISON OF THREE METHODS OF TARGETING THE SUBTHALAMIC NUCLEUS FOR CHRONIC STIMULATION IN PARKINSON'S DISEASE
000574 Cindy Zadikoff [États-Unis, Canada] ; Susan H. Fox [Canada] ; David F. Tang-Wai [Canada] ; Teri Thomsen [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Pettarusup Wadia [Canada] ; Janis Miyasaki [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada]A Comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in Identifying Cognitive Deficits in Parkinson's Disease
000578 Asha Kishore [Canada] ; Alberto J. Espay [Canada] ; Connie Marras [Canada] ; Thamer Al-Khairalla [Canada] ; Tamara Arenovich [Canada] ; Abena Asante [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada]Unilateral versus bilateral tasks in early asymmetric Parkinson's disease : Differential effects on bradykinesia
000641 Cindy M. De Frias [Canada] ; Roger A. Dixon [Canada] ; Nancy Fisher [Canada] ; Richard Camicioli [Canada]Intraindividual variability in neurocognitive speed: A comparison of Parkinson's disease and normal older adults
000719 Catherine L. Burton [Canada] ; Esther Strauss [Canada] ; David F. Hultsch [Canada] ; Alex Moll [Canada] ; Michael A. Hunter [Canada]Intraindividual variability as a marker of neurological dysfunction : A comparison of Alzheimer's disease and Parkinson's disease
000729 Patrick S. R. Davidson [Canada] ; David Anaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Tiffany W. Chow [Canada] ; Morris Moscovitch [Canada]Exploring the recognition memory deficit in Parkinson's disease : estimates of recollection versus familiarity
000777 John R. Adams [Canada] ; Hinke Van Netten [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jessamyn Mckenzie [Canada] ; Audrey Strongosky [États-Unis] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Matthew Farrer [États-Unis] ; Thomas Gasser [Allemagne] ; Ryan J. Uitti [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; A. Jon Stoessl [Canada]PET in LRRK2 mutations : comparison to sporadic parkinson's disease and evidence for presymptomatic compensation
000791 Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie]Identification of motor and nonmotor wearing-off in Parkinson's disease : Comparison of a patient questionnaire versus a clinician assessment
000810 Victor Lun [Canada] ; Nancy Pullan [Canada] ; Nancy Labelle [Canada] ; Corey Adams [Canada] ; Oksana Suchowersky [Canada]Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease
000811 Yuri M. Andrade-Souza [Canada] ; Jason M. Schwalb [Canada] ; Clement Hamani [Canada] ; Tasnuva Hoque [Canada] ; Jean Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Kim J. Burchiel [États-Unis] ; Christopher J. Winfree [États-Unis] ; Konstantin Slavin [États-Unis]Comparison of 2-dimensional magnetic resonance imaging and 3-planar reconstruction methods for targeting the subthalamic nucleus in parkinson disease
000845 Dominique Petit [Canada] ; Jean-Francois Gagnon [Canada] ; Maria Livia Fantini [Canada] ; Luigi Ferini-Strambi [Italie] ; Jacques Montplaisir [Canada]Sleep and quantitative EEG in neurodegenerative disorders
000847 M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada]Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate
000906 Henrik Sjöström [Suisse] ; John H. J. Allum [Suisse] ; Mark G. Carpenter [Canada] ; Allan L. Adkin [Canada] ; Flurin Honegger [Suisse] ; Thierry Ettlin [Suisse]Trunk sway measures of postural stability during clinical balance tests in patients with chronic whiplash injury symptoms
000917 Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias [Canada] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni]Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
000930 S. Lincoln [États-Unis] ; J. Wiley [Irlande (pays)] ; T. Lynch [Irlande (pays)] ; J. W. Langston [États-Unis] ; R. Chen [États-Unis] ; A. Lang [Canada] ; E. Rogaeva [Canada] ; D. S. Sa [Canada] ; R. P. Munhoz [Canada] ; J. Harris [États-Unis] ; K. Marder [États-Unis] ; C. Klein [Allemagne] ; G. Bisceglio [États-Unis] ; J. Hussey [États-Unis] ; A. West [États-Unis] ; M. Hulihan [États-Unis] ; J. Hardy [États-Unis] ; M. Farrer [États-Unis]Parkin-proven disease: Common founders but divergent phenotypes
000931 William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada]Pallidal neuronal activity: Implications for models of dystonia
000935 Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada]Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
000965 Michael Iskedjian [Canada] ; Thomas R. Einarson [Canada]Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease
000967 Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis
000972 Antonio P. Strafella [Canada] ; Alain Dagher [Canada] ; Abbas F. Sadikot [Canada]Cerebral blood flow changes induced by subthalamic stimulation in Parkinson's disease
000977 David K. Simon [États-Unis] ; Jennifer Friedman ; Xandra O. Breakefield [États-Unis] ; Joseph Jankovic [États-Unis] ; Mitchell F. Brin [États-Unis] ; John Provias [Canada] ; Susan B. Bressman [États-Unis] ; Michael E. Charness [États-Unis] ; Daniel Tarsy [États-Unis] ; Donald R. Johns [États-Unis] ; Mark A. Tarnopolsky [Canada]A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia
000A22 Michel Cyr [Canada] ; Frederic Calon [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada]Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease
000A31 Robert Jr Laforce [Canada] ; Julien Doyon [Canada]Differential role for the striatum and cerebellum in response to novel movements using a motor learning paradigm
000A46 Ravikant S. Palur [Canada] ; Caglar Berk ; Michael Schulzer ; Christopher R. HoneyA metaanalysis comparing the results of pallidotomy performed using microelectrode recording or macroelectrode stimulation
000A77 Edith V. Sullivan [États-Unis] ; Paula K. Shear [États-Unis] ; Maria Stein [États-Unis] ; Rosemary Fama [États-Unis] ; Deborah A. Cahn-Weiner [États-Unis] ; Robert B. Zipursky [Canada] ; Adolf Pfefferbaum [États-Unis]Motor sequencing deficits in schizophrenia: a comparison with Parkinson's disease
000B19 Robert Jr Laforce [Canada] ; Julien Doyon [Canada]Distinct contribution of the striatum and cerebellum to motor learning
000B35 Lana Depatie [Canada] ; Samarthji Lal [Canada]Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
000C05 C. Schwab [Canada] ; P. L. Mcgeer [Canada]Aβ42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and Pick bodies
000C09 C. R. Honey [Canada] ; R. A. Nugent [Canada]A prospective randomized comparison of CT and MRI pre-operative localization for pallidotomy
000C12 O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada]A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa
000C18 K. E. Norman [Canada] ; R. Edwards [Canada] ; C. Duval [Canada] ; S. Patenaude [Canada] ; A. Beuter [Canada]Two-dimensional geometry and electromyography of spontaneous and imitated Parkinsonian wrist tremor
000C22 V. Fraïle [Canada] ; H. Cohen [Canada]Temporal control of voicing in Parkinson's disease and tardive dyskinesia speech
000C67 R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Sime [Canada] ; E. Halket [Canada] ; A. E. Lang [Canada]Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation
000C68 I. Litvan [États-Unis] ; D. A. Grimes [Canada] ; A. E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; A. Mckee [États-Unis] ; M. Verny [France] ; K. Jellinger [Autriche] ; K. R. Chaudhuri [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni]Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration
000D21 R. R. Tasker [Canada] ; R. D. Penn [États-Unis]Deep brain stimulation is preferable to thalamotomy for tremor suppression. Commentary
000D34 G. Le Dorze [Canada] ; J. Ryalls [États-Unis] ; C. Brassard [Canada] ; N. Boulanger [Canada] ; D. Ratte [Canada]A comparison of the prosodic characteristics of the speech of people with Parkinson's disease and Friedreich's ataxia with neurologically normal speakers
000D55 J. Doyon [Canada] ; D. Gaudreau [Canada] ; R. Jr Laforce [Canada] ; M. Castonguay [Canada] ; P. J. Bedard [Canada] ; F. Bedard [Canada] ; J.-P. Bouchard [Canada]Role of the striatum, cerebellum, and frontal lobes in the learning of a visuomotor sequence
000D62 R. Grondin [Canada] ; P. J. Bedard [Canada] ; D. R. Britton [États-Unis] ; K. Shiosaki [États-Unis]Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929 : An acute study in parkinsonian levodopa-primed monkeys
000D67 P. Caffarra [Italie] ; L. Riggio [Italie] ; L. Malvezzi [Italie] ; A. Scaglioni [Italie] ; M. Freedman [États-Unis, Canada]Orienting of visual attention in Alzheimer's disease : Its implication in favor of the interhemispheric balance
000D98 M. Freedman [Canada] ; M. Oscar-Berman [États-Unis]Breakdown of cross-modal function in dementia
000E03 B. J. Cade-Menun [Canada] ; L. M. Lavkulich [Canada]A comparison of methods to determine total, organic, and available phosphorus in forest soils
000E32 C. Schwab [Canada] ; J. C. Steele ; H. Akiyama [Japon] ; P. L. Mcgeer [Canada]Distinct distribution of apolipoprotein E and β-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam
000E49 XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada]Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy
000F15 M. Huberman [Canada] ; M. Moscovitch ; M. Freedman [Canada]Comparison of patients with Alzheimer's and Parkinson's disease on different explicit and implicit tests of memory
000F17 R. Lemery [Canada] ; M. Talajic ; D. Roy ; A. Fournier ; B. Coutu ; J. T. Y. Hiii ; D. Radzik ; L. LavoieCatheter ablation using radiofrequency of low-energy direct current in pediatridc patients with the Wolff-Parkinson-White syndrome
000F25 R. Lemery [Canada] ; M. Talajic ; D. Roy ; L. Lavoie ; B. Coutu ; J. T. Y. Hii ; D. Radzik ; E. Lavallee ; R. CartierResults of a comparative study of low energy direct current with radiofrequency ablation in patients with the Wolff-Parkinson-White syndrome
000F51 R. Quirion [Canada]Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release
000F53 D. L. Jones [Canada] ; G. J. Klein ; G. M. Guiraudon ; R. YeeBiphasic versus sequential pulse defibrillation : a direct comparison in humans
001010 M. Cordes [Canada] ; B. J. Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D. B. CalneL-18F-DOPA-PET bei Parkinson-Plus-Syndromen zum Nachweis einer gestörten präsynaptischen dopaminergen Funktion
001036 C. Giorgi ; R. Nadeau ; P. Savard ; M. Shenasa ; P. L. Page ; R. CardinalBody surface isopotential mapping of the entire QRST complex in the Wolff-Parkinson-White syndrome. Correlation with the location of the accessory pathway
001046 P. L. Page [Canada] ; L. C. Pelletier ; W. Kaltenbrunner ; E. Vitali ; D. Roy ; R. NadeauSurgical treatment of the Wolff-Parkinson-White syndrome : endocardial versus epicardial approach
001052 C. Hertzman [Canada] ; M. Wiens ; D. Bowering ; B. Snow ; D. CalneParkinson's disease: a case-control study of occupational and environmental risk factors
001055 E. R. Vriezen [Canada] ; M. MoscovitchMemory for temporal order and conditional associative-learning in patients with Parkinson's disease
001059 A. J. Hudson ; G. P. A. RiceHipothesis : similitaries of guamanian ALS/PD to post-encephalitic Parkinsonism/ALS : possible viral cause
001060 R. Turcotte ; C. Godin ; R. Duchesne ; A. JodoinHip fractures and Parkinson's disease : a clinical review of 94 fractures treated surgically
001126 P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di PaoloBehavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys
001155 S. Milstein ; G. J. Klein ; M. F. Rattes ; A. D. Sharma ; R. YeeComparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome
001159 I. Libman ; M. J. Gawel ; R. J. Riopelle ; S. BouchardA comparison of bromocriptine (Parlodel®) and levodopa-carbidopa (Sinemet®) for treatment of "De Novö Parkinson's disease patients
001184 P. J. Bedard ; T. Di Paolo ; P. Falardeau ; R. BoucherChronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3H]spiperone binding

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022